• Establishing Organoids from Breast Adenomyoepithelioma: Meth

  2026-05-15

  This study presents the first successful establishment and characterization of patient-derived organoids from adenomyoepithelioma (AME) of the breast, a rare neoplasm with poorly understood pathogenesis. The organoid platform closely recapitulates the original tumor’s characteristics and demonstrates potential for preclinical drug sensitivity testing, supporting future research in rare breast tumor biology.

• Berberrubine Chloride: Applied Cancer Research Workflows

  2026-05-15

  Berberrubine chloride uniquely empowers researchers to target IMPDH2 in colorectal and lung cancer models with selective, quantifiable inhibition. This article unpacks advanced protocols, troubleshooting strategies, and translational insights for maximizing reproducibility and biological impact in preclinical workflows.

• EdU Imaging Kits (Cy5): Precision S-Phase DNA Synthesis Dete

  2026-05-14

  EdU Imaging Kits (Cy5) deliver high-sensitivity, no-denaturation cell proliferation analysis, streamlining workflows in both microscopy and flow cytometry. Their click chemistry approach empowers researchers to capture S-phase events with unmatched clarity and robustness—even in complex experimental settings.

• Cy5.5 NHS Ester (Non-Sulfonated): Benchmarks in Fluorescence

  2026-05-14

  Cy5.5 NHS ester (non-sulfonated) is a high-performance near-infrared fluorescent dye for covalent biomolecule labeling. Its robust optical properties and stability enable sensitive in vivo fluorescence imaging and tumor visualization. This article enumerates its action mechanism, supporting evidence, applications, and key protocol parameters.

• ABCC10-Driven cGAMP Efflux Links Metabolism to Radioresistan

  2026-05-13

  This study identifies ABCC10 as a novel ATP-dependent exporter of 2'3'-cGAMP in cancer cells, revealing a mechanism that dampens STING-mediated innate immune responses and contributes to radiotherapy resistance. The findings provide new insight into metabolic adaptation in tumors and highlight ABCC10 as both a potential biomarker for radiotherapy response and a therapeutic target.

• Prevotella copri-Induced IPA Depletion Drives Breast Cancer

  2026-05-13

  This study reveals that gut Prevotella copri depletes host indole-3-pyruvic acid (IPA), promoting breast cancer by disrupting AMPK signaling via UHRF1 upregulation. The findings provide a mechanistic link between microbial tryptophan metabolism and tumor progression, informing future microbiome and metabolic interventions.

• HyperFusion High-Fidelity DNA Polymerase: Precision in Neuro

  2026-05-12

  HyperFusion™ high-fidelity DNA polymerase empowers researchers to achieve rapid, error-free PCR even with challenging GC-rich or long templates. Its superior proofreading activity and inhibitor tolerance streamline cloning, sequencing, and neurogenomic workflows—especially where fidelity is mission-critical.

• Artemisitene Induces Calcium-Dependent Ferroptosis in Colore

  2026-05-12

  This study uncovers a novel mechanism by which artemisitene triggers ferroptosis in colorectal cancer cells via disruption of the LSH-EWSR1 interaction and downstream calcium signaling modulation. These findings highlight new therapeutic opportunities targeting noncanonical ferroptosis pathways in treatment-resistant colorectal cancer.

• Aβ42 Peptide Triggers Microglial Phagocytosis in Alzheimer’s

  2026-05-11

  Kopec and Carroll (1998) demonstrated that Amyloid β-Peptide (1-42) (Aβ42) fibrils directly stimulate murine microglial phagocytosis in a time- and dose-dependent fashion. This work advanced understanding of microglial immune responses to amyloid pathology and provided evidence for extracellular matrix modulation of Aβ42 uptake, informing experimental strategies in Alzheimer’s disease research.

• Moesin as a Biomarker of Endothelial Injury in Sepsis Models

  2026-05-11

  The referenced study identifies moesin (MSN) as a novel serum biomarker for endothelial injury severity in sepsis, demonstrating its correlation with clinical indices and mechanistic involvement in endothelial dysfunction. These findings help refine experimental models for vascular injury and provide a foundation for mechanistic studies targeting the endothelial barrier in sepsis.

• Disulfiram (SKU A4015): Reliable Proteasome & Pyroptosis Too

  2026-05-10

  Disulfiram (SKU A4015) from APExBIO offers reproducible, quantitative solutions for cell viability, cytotoxicity, and apoptosis pathway assays in cancer and inflammasome research. This article explores real-world scenarios, evidencing how Disulfiram’s validated solubility, mechanistic specificity, and workflow compatibility address core laboratory challenges. The piece emphasizes protocol clarity, cross-study reliability, and actionable guidance for biomedical researchers.

• Cabozantinib (XL184): Advanced Multi-Kinase Inhibition in Ca

  2026-05-09

  Explore how Cabozantinib (XL184) uniquely remodels phosphorylation and adhesion signaling in cancer models. This in-depth analysis unveils practical assay insights and new experimental strategies for antiangiogenic research.

• A40926: Regulatory Innovations and Assay Precision for Next-

  2026-05-09

  Explore the scientific depth of A40926 as a dalbavancin precursor, focusing on its biosynthetic regulation, assay optimization, and impact on Gram-positive bacterial infection research. This article uniquely analyzes regulatory cross-talk and assay design, offering advanced insights for antibiotic innovation.

• Dasatinib Monohydrate in Assembloid Models: New Frontiers in

  2026-05-08

  This article provides translational researchers with a mechanistic and strategic perspective on the use of Dasatinib Monohydrate (BMS-354825) in advanced patient-derived tumor assembloid models. By synthesizing recent evidence and practical workflow guidance, it highlights how APExBIO’s Dasatinib Monohydrate empowers the study of kinase-driven resistance, tumor–stroma interactions, and the design of next-generation precision therapies, particularly in the context of chronic myeloid leukemia and Philadelphia chromosome positive leukemias. This piece advances the discussion beyond standard product pages through critical evidence integration, competitive landscape analysis, and actionable protocol parameters for translational teams.

• p-Cresyl Sulfate Drives Aortic Valve Calcification via Kloth

  2026-05-07

  This study demonstrates that p-cresyl sulfate (PCS), a protein-bound uremic toxin, accelerates calcification in aortic valvular interstitial cells by suppressing klotho/SIRT1 signaling and activating pro-calcific pathways. These mechanistic insights clarify how PCS contributes to cardiovascular risk in chronic kidney disease and highlight potential therapeutic targets for intervention.

461 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page